BRIDGEWATER – Gov. Phil Murphy attended the opening of corporate offices for an international pharmaceutical company in the ...
MUMBAI, India and NAPLES, Fla. and SAN DIEGO, July 15, 2024 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) announced today ...
Furthering U.S.-based pharmaceutical capacity in Coral Springs, Florida to produce critical respiratory medicines and to strengthen the company's position as a global respiratory leader. CORAL SPRINGS ...
Unlike competitors that rushed to market, Lupin spent its early years conducting trials and publishing peer-reviewed studies ...
The new space expands Lupin's footprint in New Jersey, underscoring its strong commitment to advancing pharmaceutical ...
Global pharma major Lupin Limited (Lupin), announced its wholly owned subsidiary, Nanomi B.V. (Nanomi), has signed a definitive agreement for the acquisition of VISUfarma B.V. (VISUfarma), a portfolio ...
Lupin Limited recently inaugurated new corporate offices at 100 Somerset Corporate Blvd in Bridgewater, New Jersey with a ribbon-cutting ceremony attended by Governor Phil Murphy and Somerset County ...
Catalyst Pharmaceuticals (NASDAQ:CPRX) said that the company and licensor SERB S.A. signed a settlement agreement with Lupin Pharmaceuticals, putting an end to a patent lawsuit. The lawsuit was in ...
The AI-powered platform aims to help working professionals manage cardiometabolic risks through heart-age tracking, ...
AstraZeneca and Daiichi Sankyo are teeing up a TROP2 showdown with Gilead Sciences in first-line triple-negative breast cancer. China's InnoCare Pharma agreed to out-license three autoimmune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback